Methylphenidate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

10 API Suppliers, 5 USDMF, 1 EU WC, 5 NDC API, 6 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

20 Intermediates Suppliers

20 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

120 FDF Dossiers, 15 FDA Orange Book, 56 Europe, 24 Australia, 16 South Africa, 9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - 17.3MG, TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - 25.9MG, TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - 34.6MG, TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - 8.6MG

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 14 SPI Pharma, 2 Seqens, 1 DKSH, 1 Pharm-RX Chemical, 3 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Actylis, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 14 BASF, 1 Bioplus Life Sciences, 6 Corel Pharma Chem, 2 DFE Pharma, 3 Doshion Polyscience, 1 Finar, 7 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 6 Kerry, 1 Kima Chemical, 10 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 10 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 1 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

42 Fillers, Diluents & Binders, 28 Direct Compression, 19 Taste Masking, 19 Thickeners and Stabilizers, 16 Disintegrants & Superdisintegrants, 15 Granulation, 14 Chewable & Orodispersible Aids, 12 Co-Processed Excipients, 12 Controlled & Modified Release, 12 Coating Systems & Additives, 11 Lubricants & Glidants, 7 Film Formers & Plasticizers, 7 Solubilizers, 7 Topical, 7 Parenteral, 3 Emulsifying Agents, 2 API Stability Enhancers, 1 Surfactant & Foaming Agents, 1 Rheology Modifiers

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 38 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 60 Finished Drug Prices, 12 Annual Reports

MARKET PLACE

9 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

24 US Patents

24 US Patents

REF. STANDARDS & IMPURITIES

2 Others

2 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 205489 / DOSAGE - TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - 17.3MG

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
METHYLPHENIDATE(UNII: 207ZZ9QZ49) (METHYLPHENIDATE - UNII:207ZZ9QZ49)	METHYLPHENIDATE	25.9mg \| 8.6mg \| 17.3mg

Inactive Ingredients

Ingredient Name	Neos Therapeutics Brands, LLC
CITRIC ACID MONOHYDRATE(2968PHW8QP)
CROSPOVIDONE(2S7830E561)
ETHYLCELLULOSE, UNSPECIFIED(7Z8S9VYZ4B)
FRUCTOSE(6YSS42VSEV)
MAGNESIUM STEARATE(70097M6I30)
MANNITOL(3OWL53L36A)
METHACRYLIC ACID(1CS02G8656)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A)
POLYSTYRENE SULFONIC ACID(70KO0R01RY)
SILICON DIOXIDE(ETJ7Z6XBU4)
SUCRALOSE(96K6UQ3ZD4)
TRIETHYL CITRATE(8Z96QXD6UM)

Drug Product Composition: Methylphenidate